A role for common genomic variants in the assessment of familial breast cancer

scientific article published on 29 October 2012

A role for common genomic variants in the assessment of familial breast cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.2012.41.7469
P698PubMed publication ID23109704

P50authorGeorgia Chenevix-TrenchQ17517031
Geoffrey J. LindemanQ42337443
David BowtellQ47451431
P2093author name stringGillian Mitchell
Paul A James
Jonathan Beesley
Alison H Trainer
Joanne McKinley
Marion Harris
Xiao Qing Chen
Sarah Sawyer
P433issue35
P921main subjectbreast cancerQ128581
P304page(s)4330-4336
P577publication date2012-10-29
P1433published inJournal of Clinical OncologyQ400292
P1476titleA role for common genomic variants in the assessment of familial breast cancer
P478volume30

Reverse relations

cites work (P2860)
Q62712290BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding
Q37060585Behavioral and psychosocial responses to genomic testing for colorectal cancer risk
Q40605693Breast cancer risk prediction using a clinical risk model and polygenic risk score
Q37410693Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab
Q89746441Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field
Q38996690Clinical implications of genomics for cancer risk genetics
Q37690575Common breast cancer risk variants in the post-COGS era: a comprehensive review
Q52875169Diagnosis and Management of Hereditary Sarcoma.
Q37699255Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling
Q34767345Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer
Q35832873Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
Q64080586Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Q44770193Genetic risk transmission in a family affected by familial breast cancer
Q47207156Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry
Q37242239Genomic Biomarkers for Breast Cancer Risk
Q64934338High-risk women's risk perception after receiving personalized polygenic breast cancer risk information.
Q41441053Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features
Q37583113Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status
Q47822347Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Q32491318Monogenic and polygenic determinants of sarcoma risk: an international genetic study
Q37079859No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Q47554600Population-Wide Genetic Risk Prediction of Complex Diseases: A Pilot Feasibility Study in Macau Population for Precision Public Healthcare Planning
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q35964605Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
Q33916899Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study
Q36146953Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context
Q41387543Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients
Q92993050Systematic evaluation of cancer-specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts
Q54269445The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia.
Q64240122Towards a more precise and individualized assessment of breast cancer risk
Q37003285Tumour morphology predicts PALB2 germline mutation status
Q33820594Two decades after BRCA: setting paradigms in personalized cancer care and prevention
Q34586198Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles

Search more.